Results 301 to 310 of about 224,997 (329)
Some of the next articles are maybe not open access.
Nonalcoholic Fatty Liver Disease
Pediatric Annals, 2006NAFLD likely is the most common liver disease in children and is responsible for significant progression to cirrhosis, portal hypertension, and the need for liver transplantation in adults and even in some adolescents. Early diagnosis and lifestyle interventions appear to be our best hope for controlling progression of disease.
Marcos E, Alfire, William R, Treem
openaire +2 more sources
CKD and Nonalcoholic Fatty Liver Disease
American Journal of Kidney Diseases, 2014The possible link between nonalcoholic fatty liver disease and chronic kidney disease (CKD) recently has attracted considerable scientific interest. Accumulating clinical evidence indicates that the presence and severity of nonalcoholic fatty liver disease is associated significantly with CKD (defined as decreased estimated glomerular filtration rate ...
TARGHER, Giovanni, MB Chonchol, Byrne CD
openaire +4 more sources
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Clinics in Liver Disease, 2004Nonalcoholic fatty liver disease (NAFLD) is a well-recognized form of chronic liver disease affecting both children and adults that has gained increased recognition. Recently NAFLD has been associated with insulin resistance and its incidence and prevalence is likely increasing, paralleling the rise in obesity and diabetes mellitus in the United States.
Stephen A, Harrison +1 more
openaire +2 more sources
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.
Metabolism: Clinical and Experimental, 2019The obesity epidemic is closely associated with the rising prevalence and severity of nonalcoholic fatty liver disease (NAFLD): obesity has been linked not only with simple steatosis (SS), but also with advanced disease, i.e., nonalcoholic ...
S. Polyzos, J. Kountouras, C. Mantzoros
semanticscholar +1 more source
Nonalcoholic Fatty Liver Disease in Children
Journal of the American College of Nutrition, 2008In view of the epidemic obesity in childhood, facing the disease and its associated morbidities early at this age becomes crucial for public health researchers and care givers. The present review focuses on pediatric Non Alcoholic Fatty Liver Disease (NAFLD) among co-morbidities, being the disease yet under diagnosed and under treated despite a ...
Manco, Melania +5 more
openaire +3 more sources
Nonalcoholic fatty liver disease
Current Gastroenterology Reports, 1999The definition of nonalcoholic fatty liver disease has evolved in recent years. Today, it is considered a nonspecific term encompassing several clinicopathologic entities (steatosis alone, steatonecrosis, steatohepatitis and histologic alcoholic-like hepatitis) that are similar to alcoholic liver disease.
openaire +2 more sources
Nonalcoholic Fatty Liver Disease Is Related to Nonalcoholic Fatty Pancreas Disease
Pancreas, 2010Obesity and insulin resistance cause fatty infiltration of many organs, including the pancreas (pancreatic steatosis [PS]) and the liver (nonalcoholic fatty liver disease [NAFLD]). In contrast to NAFLD, pathophysiological mechanisms and clinical relevance of PS remain unknown.
van Geenen, E.J.M. +5 more
openaire +3 more sources
Nonalcoholic Fatty Liver Disease
New England Journal of Medicine, 2022Bilal A, Mir +2 more
openaire +4 more sources
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation
Clinics in Liver Disease, 2018The number of transplants caused by nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NASH) has been progressively increasing and this is expected to become the most common indication for liver transplant in the United States. Patients with NASH show many features of the metabolic syndrome and, as a result, are at higher risk for ...
Danielle, Carter +2 more
openaire +2 more sources
Nonalcoholic fatty liver disease and statins
Metabolism, 2015Nonalcoholic fatty liver disease (NAFLD) is the most frequent cause of elevated transaminase levels and affects approximately one third of the general population. Patients with NAFLD are at increased risk for cardiovascular events, which represent the leading cause of death in this population.
Konstantinos, Tziomalos +3 more
openaire +2 more sources

